Mitchell Clark

Assistant Professor @YaleMed Gyn-Oncology Former Gyn-Oncology Fellow @UofTMedicine #AVGeek, Frequent Flyer. Opinions are my own.

[Mitchell Clark @MClark_GYO]

Farewell dinner and oral presentation practice for my amazing summer student Natalia from @uccaribe in PR! Thanks to @YaleMed #DICE office for inviting me to be a mentor. Our future in OBGYN is bright!

[ESGO @ESGO_society]

Looking for some weekend reading? 🗞🤓 Check out the ESGO Prevention Committee’s review article on myths & fake messages about HPV vaccination, which was just published in the @IJGConline 👉 https://t.co/zEcWlOZjUv

@ENYGO_official @OncoAlert @EngageEsgo

[Yale Surgery @YaleSurgery]

From one legendary leader to another ... Dr. Ronald Salem passes the torch to Dr. Kiran Turaga. Welcome to #YaleSurgery @kturaga! @YaleCancer @YaleMedicine https://t.co/Xpr7lRbe34

[Mitchell Clark @MClark_GYO]

@BrianBinghamMD Same convo with the same insurer. Insanity.

[Mitchell Clark @MClark_GYO]

Trying to keep the holiday spirit alive in these difficult times! Happy holidays to those working and those enjoying some much needed time off. #gynonc #oncall

[MSK Library @MSKLibrary]

Featured today by @MSKLibrary: A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancer... https://t.co/LnuIo9cLWR @nataliabuzamd @Hui2Pei @ElenOnAir @NupurNagarkatti @samirzaidi @MClark_GYO @VirusesImmunity @ericsongg

[Mitchell Clark @MClark_GYO]

Thrilled to be included as a research mentor and expand the program into #gynonc for @YaleMed DICE summer research program! Inspiring the next generation of #gyncancer leaders.

https://t.co/J0dQ6N8z5U

[Mitchell Clark @MClark_GYO]

@SabrinaPiedimo1

[Gynecologic Cancer Initiative @GCI_Cluster]

Join us next week for our final Research Rounds of the year with @SabrinaPiedimo1! She will be presenting on the application of machine learning algorithms to predict recurrence in high grade endometrial cancer. Learn more about research rounds ⏩ https://t.co/Wb73CU7TJ2

[Mitchell Clark @MClark_GYO]

Teaching surgical skills to the @YaleMed OBGYN student interest group with @vaflores7 !

[Mitchell Clark @MClark_GYO]

Thank you to @WVUMedSchool OBGYN for the invitation to give Grand Rounds. A wonderful group engaged in the mission to end #cervicalcancer

[Mitchell Clark @MClark_GYO]

@ChristiKimMD Thanks for featuring our paper! Hoping for new and exciting options for these women.

[Mitchell Clark @MClark_GYO]

Dr. Mitchell Clark Shares Why He Works in Cancer Research https://t.co/zi3SvlBYyh via @yalemed Grateful to be featured in @SmilowCancer celebration of the 50th anniversary of the National Cancer Act #GynaeCancerAwarenessMonth

[Mitchell Clark @MClark_GYO]

Join this exciting webinar! Many amazing mentors with decades of experience to help guide those early in their career.

[Mitchell Clark @MClark_GYO]

Thrilled to see these results for women with #cervicalcancer ! #immunotherapy prolongs survival.

[Brian Slomovitz, MD, MS, FACOG @GynCancerMD]

Major breakthrough for patients with cervical cancer. Add immunotherapy to first line therapy and patients live longer!! @myESMO @IJGConline @gog @NEJM

[Mitchell Clark @MClark_GYO]

@eberger32 Amazing surgeon AND amazing caption writer!

[SGO @SGO_org]

Join OB/GYN Dr. Mary Jane Minkin for a 3-part lecture series focusing on hormone and drug therapies for vasomotor and sexual dysfunction symptoms in benign patients.

https://t.co/jVNd7woNGC

[Mitchell Clark @MClark_GYO]

https://t.co/XDtjmmGHjK Yes! Meant to include that :)

[Mitchell Clark @MClark_GYO]

Cervical cancer is NOT just a burden to younger women. Continued surveillance of older women improves survival.

[ASCCP @ASCCP]

Researchers found that fewer than one in three women aged 64 to 66 met the criteria to discontinue cervical cancer screening leaving women aged 65 and over at risk. #CervicalCancer #HPV https://t.co/FIENA55m1v

[Mitchell Clark @MClark_GYO]

Chemo-RT without additional #chemotherapy remains the best way to treat locally advanced #cervicalcancer. Congrats to all involved.

[The GOG Foundation Inc. @GOG]

For more information on this Late Breaking Abstract being presented during the 2021 ASCO Annual Meeting on June 6th, go to https://t.co/PLDnCZyJi0 or click in bio. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #ovariancancer #ASCO21

[SGO @SGO_org]

Diversity and inclusion is a core value of the Society of Gynecologic Oncology (SGO). This month, SGO reaffirms its unwavering commitment to the rights, health and safety of LGBTQIA+ people and the goal of health equity. #PrideMonth https://t.co/HdHpNIaIfQ